Early detection of prostate cancer. Role of prostate-specific antigen.
Pressure to request prostate-specific antigen (PSA) tests for early detection of prostate cancer in middle-aged and older men is increasing. However, current scientific data suggest that such testing does more harm than good. Most professional groups do not advise routine screening for prostate cancer. This paper reviews the current status of PSA testing.
Prabhakaran
V M
VM
Division of Biochemical Pathology, General Hospital, St John's.
D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000379:methods* / Q000592:standards; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000517:prevention & control; D015203:Reproducibility of Results
D017430:Prostate-Specific Antigen